Nitric oxide is a key molecule in migraine and other vascular headaches.
about
Agonist actions of dihydroergotamine at 5-HT2B and 5-HT2C receptors and their possible relevance to antimigraine efficacyNeuroprotective effects of non-steroidal anti-inflammatory drugs by direct scavenging of nitric oxide radicalsIncrease in meningeal blood flow by nitric oxide--interaction with calcitonin gene-related peptide receptor and prostaglandin synthesis inhibitionImpaired vasodilator response to organic nitrates in isolated basilar arteriesSecondary headaches: secondary or still primary?Involvement of nitric oxide in the modulation of dural arterial blood flow in the rat.Pharmacological evidence for the 5-HT7 receptor mediating smooth muscle relaxation in canine cerebral arteriesMigraine aura pathophysiology: the role of blood vessels and microembolisationMicroemboli may link spreading depression, migraine aura, and patent foramen ovale.Recurrent headaches may be caused by cerebral toxoplasmosisDiencephalic and brainstem mechanisms in migraine.Modelling headache and migraine and its pharmacological manipulationEndothelial 5-HT receptors mediate relaxation of porcine pulmonary arteries in response to ergotamine and dihydroergotamine.Nitric oxide-induced headache may arise from extracerebral arteries as judged from tolerance to isosorbide-5-mononitrate.Intracranial hemodynamics during intravenous infusion of glyceryl trinitrate.NO pain: potential roles of nitric oxide in neuropathic pain.Enhanced nitric oxide release during cortical spreading depression following infusion of glyceryl trinitrate in the anaesthetized cat.Vascular extracellular signal-regulated kinase mediates migraine-related sensitization of meningeal nociceptors.From migraine to chronic daily headache: the biological basis of headache transformation.Is there hope for chronic pain and headache?Peripheral Sensory Neurons Expressing Melanopsin Respond to Light.The blood-brain barrier in migraine treatment.CGRP receptor antagonism and migraine.Genetic aspects of cluster headache.Role of magnesium in the pathogenesis and treatment of migraine.Nitroglycerin enhances the propagation of cortical spreading depression: comparative studies with sumatriptan and novel kynurenic acid analoguesReactive oxygen species induce procalcitonin expression in trigeminal ganglia gliaNitric oxide-related drug targets in headache.Pathophysiology of medication overuse headache: insights and hypotheses from preclinical studies.Chemical mediators of migraine: preclinical and clinical observations.The science of migraine.Why all migraine patients should be treated with magnesium.Migraine and metabolism.Update on future headache treatments.L-arginine and nitric oxide in CNS function and neurodegenerative diseases.Emerging targets in migraine.The effect of sumatriptan on nitric oxide synthase enzyme production after iatrogenic inflammation in the brain stem of adolescent rats: A randomized, controlled, experimental studyCerebral hemodynamics in the different phases of migraine and cluster headache.Towards a pragmatic human migraine model for drug testing: 2. Isosorbide-5-mononitrate in healthy individuals.Brain natriuretic peptide constitutively downregulates P2X3 receptors by controlling their phosphorylation state and membrane localization
P2860
Q24321991-61032F5C-ED69-47EC-A798-B5BCA05C0606Q28180514-1CD00097-4C10-4193-A67C-A23C88499926Q28193135-D7710D32-A46D-46FC-B473-88FD3818D4FEQ28345803-99C7063E-60CE-4C9F-B556-ACA728E773F4Q30466781-2541C242-F516-490A-9F33-FC92AC6D35BCQ30853246-05B91CED-F48B-454C-B4C2-D647755BF46EQ33867649-1ADA8BF2-6090-4B8A-842A-22EC27809CAEQ34066772-2E2FC579-A2D0-4874-9D50-3DAB72E5F7C1Q34066973-395E3F37-A8AC-4327-9463-D3672C944057Q34171704-349B0FFD-E7B8-4115-A95E-90654BCC20AAQ34217686-CFDD1968-6B33-43F2-AEFE-B8D8EC23A73DQ34407137-810DBA78-EDCF-4C44-99B7-77E1DD020689Q35884702-23F7428D-B01B-4CD8-ACE1-6C1D84E6D85CQ36260227-483EFEA5-B89B-4ACE-8D67-B0F829C2F456Q36332589-0564BDE0-97CD-4CDB-B85A-C721A942A045Q36665360-53AA7D48-D3A1-414F-A3B6-EF04AF31EF95Q36863501-944A3521-2C73-4B08-9E69-D563BBCB3D00Q36944819-19078E08-7D4C-4604-8A61-4E7CF8307FAFQ36947165-7E71B912-9F95-4EF7-BC51-9667BB0FA064Q36947170-05A76171-40C4-4571-BF68-64984BC983B5Q37162547-FFB105BC-83E0-4921-AB73-8BD2151BBF0BQ37252452-745DF31C-0B55-49A8-8716-33503A1728E7Q37374122-62A66D84-07AD-48AE-B9A4-F04FB00CC239Q37409494-71F81598-22EF-4244-9FD8-E9A6B2F903F3Q37409498-4F2E4220-02D6-4864-A54A-0517AB31CE43Q37538111-7BF7FD54-4671-45F4-8D5A-2DADAF86384DQ37627012-3E5E5920-C689-467F-A9ED-82B678D09CADQ37739589-02F072F4-E0C5-463A-BA42-2E114AC6F687Q37858847-E116063B-91BC-4CA6-BAB5-9F724227A007Q37883455-9F1868F4-E34B-4BC8-93E2-5E490243DFF4Q37986274-AC99BF0F-25DA-45B3-93DE-31D8A1A88A33Q37994599-C566079C-7A27-4670-AB32-5CF5639B42D5Q38014288-031BC0F9-7BF2-4CA6-8F35-3390053E9F71Q38108486-8F68B92A-74A0-41D7-A33C-DDBD9A86394CQ38134415-860B9F9B-AACB-4B33-9E89-0FDF9346F793Q38169593-0794E4D3-4983-453C-AA33-2B2B7B43C360Q38536449-648DAEAA-8045-4C07-9F3E-4CD85CAC7685Q38635129-E08453BF-6A0F-4CAB-BD69-64EB3EF9E69EQ38902228-F4FF710C-66E8-4D94-9AF0-B4215A1462FFQ38942004-A1B00EAE-DF44-4827-91B6-67312C285B5D
P2860
Nitric oxide is a key molecule in migraine and other vascular headaches.
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
1994年论文
@zh
1994年论文
@zh-cn
name
Nitric oxide is a key molecule in migraine and other vascular headaches.
@en
type
label
Nitric oxide is a key molecule in migraine and other vascular headaches.
@en
prefLabel
Nitric oxide is a key molecule in migraine and other vascular headaches.
@en
P1476
Nitric oxide is a key molecule in migraine and other vascular headaches
@en
P2093
L L Thomsen
P304
P356
10.1016/0165-6147(94)90075-2
P577
1994-05-01T00:00:00Z